| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the diagnosis of tuberculosis- Journey from smear microscopy to whole genome sequencing
|
Chopra, K.K.
|
|
|
|
4S |
p. S61-S68
|
artikel
|
| 2 |
Adverse drug reactions & drug interactions in MDR-TB patients
|
Gupta, Amitesh
|
|
|
|
4S |
p. S69-S78
|
artikel
|
| 3 |
Benefits and limitations of serological assays in COVID-19 infection
|
Sidiq, Zeeshan
|
|
|
|
4S |
p. S163-S166
|
artikel
|
| 4 |
Case finding strategies under National Tuberculosis Elimination Programme (NTEP)
|
Saini, Varinder
|
|
|
|
4S |
p. S101-S106
|
artikel
|
| 5 |
COVID-19 -Tuberculosis interactions: When dark forces collide
|
Udwadia, Zarir F.
|
|
|
|
4S |
p. S155-S162
|
artikel
|
| 6 |
Doing things right and knowing what's happening in tuberculosis
|
Rieder, Hans L.
|
|
|
|
4S |
p. S1-S2
|
artikel
|
| 7 |
Evolution of newer regimens in TB from RNTCP to NTEP
|
Gupta, Aditi
|
|
|
|
4S |
p. S107-S110
|
artikel
|
| 8 |
Genital tb-diagnostic algorithm and treatment
|
Sharma, Jai Bhagwan
|
|
|
|
4S |
p. S111-S118
|
artikel
|
| 9 |
Hydroxychloroquine and COVID-19 – A narrative review
|
Bajpai, Jyoti
|
|
|
|
4S |
p. S147-S154
|
artikel
|
| 10 |
Laboratory diagnosis of novel corona virus (2019-nCoV)-present and the future
|
Sidiq, Zeeshan
|
|
|
|
4S |
p. S128-S131
|
artikel
|
| 11 |
Latent TB (LTBI) treatment: Challenges in India with an eye on 2025
|
Rajpal, Sanjay
|
|
|
|
4S |
p. S43-S47
|
artikel
|
| 12 |
Lessons from healthcare personnel screening and management during H1N1 pandemic in preparation for the impending COVID-19 pandemic in a tertiary care hospital in India
|
Isaac, Barney T.J.
|
|
|
|
4S |
p. S122-S127
|
artikel
|
| 13 |
Lessons to be learnt from 100 year old 1918 influenza pandemic viz a viz 2019 corona pandemic with an eye on NTEP
|
Matta, Shanker
|
|
|
|
4S |
p. S132-S138
|
artikel
|
| 14 |
Management of latent TB infection in people living with HIV – AIDS
|
Sridhar, R.
|
|
|
|
4S |
p. S96-S100
|
artikel
|
| 15 |
Morbidity and mortality trends of Covid 19 in top 10 countries
|
Matta, Shanker
|
|
|
|
4S |
p. S167-S172
|
artikel
|
| 16 |
Paradigm shift in efforts to end TB by 2025
|
Sachdeva, K.S.
|
|
|
|
4S |
p. S48-S60
|
artikel
|
| 17 |
Principles of chemotherapy for tuberculosis in national tuberculosis programmes of low- and middle-income countries
|
Chiang, Chen-Yuan
|
|
|
|
4S |
p. S16-S22
|
artikel
|
| 18 |
Problems faced by tuberculosis patients during COVID-19 pandemic: Urgent need to intervene
|
Rai, Deependra Kumar
|
|
|
|
4S |
p. S173-S174
|
artikel
|
| 19 |
Surveillance of tuberculosis
|
Schwoebel, Valérie
|
|
|
|
4S |
p. S33-S42
|
artikel
|
| 20 |
The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India
|
Bhargava, Anurag
|
|
|
|
4S |
p. S139-S146
|
artikel
|
| 21 |
Training strategies practiced for TB elimination
|
Somashekar, Narasimhaiah
|
|
|
|
4S |
p. S79-S85
|
artikel
|
| 22 |
Tuberculosis among prisoners & health care workers
|
Bhargava, Salil
|
|
|
|
4S |
p. S91-S95
|
artikel
|
| 23 |
Tuberculosis and COVID-19 in India- double trouble!
|
Iyengar, Karthikeyan P.
|
|
|
|
4S |
p. S175-S176
|
artikel
|
| 24 |
Tuberculosis chemotherapy centre – The beginning
|
Radhakrishna, S.
|
|
|
|
4S |
p. S3-S6
|
artikel
|
| 25 |
Tuberculosis: Newer diagnostic tests: Applications and limitations
|
Chopra, K.K.
|
|
|
|
4S |
p. S86-S90
|
artikel
|
| 26 |
Tuberculosis research conducted over the years at the ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT)
|
National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), ICMR-NIRT, Chennai,
|
|
|
|
4S |
p. S7-S15
|
artikel
|
| 27 |
Using artificial intelligence for pulmonary TB prevention, diagnosis, and treatment
|
Jain, Manoj
|
|
|
|
4S |
p. S119-S121
|
artikel
|
| 28 |
What is operational research and how can national tuberculosis programmes in low- and middle-income countries use it to end TB?
|
Kumar, Ajay MV.
|
|
|
|
4S |
p. S23-S32
|
artikel
|
Tijdschrift beschrijving